Yes. The agent can be configured with detailed descriptions of your test portfolio, including carrier screening, hereditary cancer panels, pharmacogenomics, whole genome sequencing, and prenatal testing. It explains each test's purpose, methodology, and expected outcomes in patient-friendly language, helping visitors self-select the appropriate screening.

Tars integrates with over 600 platforms including Salesforce, HubSpot, Zoho CRM, and Google Sheets. For laboratory-specific systems, the platform supports custom integrations via webhooks, REST APIs, and Zapier, allowing lead and order data to flow into your LIMS or CRM automatically.

Yes. Tars is HIPAA compliant, SOC 2 Type 2 certified, GDPR compliant, and ISO certified. All patient data, including family medical histories and genetic screening interests, is encrypted in transit and at rest. The platform supports Business Associate Agreements and meets the data protection standards required for handling genetic health information.

Absolutely. The agent identifies whether the visitor is an individual patient, a referring physician, or a research partner at the beginning of the conversation. Each audience type follows a tailored path with relevant questions and information, ensuring both patient leads and physician referrals are captured with the appropriate context.

The agent asks structured questions about the patient's family medical history, personal health concerns, age, ethnicity (where clinically relevant for certain screenings), and whether a physician has recommended testing. Based on these responses, it recommends relevant screening panels from your catalog and explains why each test may be appropriate.

Yes. The agent can collect the patient's insurance provider and plan details, then provide general guidance on whether genetic tests are typically covered by their plan type. For more precise verification, it can capture insurance information and flag it for your billing team to confirm coverage before the test is ordered.

Most companies go live within a few days. Tars provides pre-built healthcare conversation flows that your team customizes with your test catalog, qualification criteria, and integration settings. The platform requires no coding for setup, and adjustments can be made at any time through a visual conversation editor.

Genetic testing companies deploying conversational AI agents typically see website conversion rates improve from 3-5% to 8-15%. The improvement comes from the agent's ability to answer questions in real time, address concerns about the testing process, and guide visitors toward the next step while their interest is high, rather than sending them to a static form or phone number.